CSQR (CSQR) News & EventsCSQRCSQR

Stocks Open Lower as Middle East Uncertainty Grows

Stocks closed lower to start the week as traders are beginning to doubt that the U.S. and Iran will reach a lasting agreement to end the war in the near term. Balancing the negative sentiment around conflict in the Middle East are strong corporate earnings and optimism around AI spending.Iran is saying it is nearing an agreement with Oman on new shipping lanes but maintaining conditions that could delay a broader reopening. Meanwhile, Iranian Foreign Minister Abbas Araghchi said over the weekend that there was "no possibility of restarting negotiations" with the U.S. as long as Washington continues to violate the June memorandum of understanding. Oil prices were higher after the news.The market is also digesting last week's unexpectedly weak July jobs report, which showed payrolls fell by 23,000 and included substantial downward revisions to prior months. The report reduced expectations for a September Fed rate hike, but the outlook remains uncertain because inflation data due this week could complicate the picture.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Intelannounced a $15Bof common stockMetaunveiled open sourceGameStop'sRyan Cohen is considering withdrawing the company's $56B bid for eBay,Archer AviationBoeing'sWisk Aero, SkyGrid, and Insitu subsidiariesMonday.comreportedand reaffirmed its FY26 revenue guidance2. WALL STREET CALLS:JefferiesAppleto Underperform on apparent all-glass iPhone cancellationSanDiskto Buy at Argus on strong fundamentals and valuationDoximityto Underweight at Wells FargoHPEto Overweight at Morgan Stanley on server and storage spendingWall Street rolled out coverage of Csquarewith3. AROUND THE WEB:A consortium of major financial institutions is partnering with Nvidiaon a potential $500B financing effort for AI infrastructure, FT reportsAmazonis planning to invest in a large natural gas power plant to supply electricity directly to a major AI data center in Texas, underscoring how rapidly rising AI compute demand is driving tech companies to secure dedicated power generation, NY Times reportsSonyand (TSMC) plan to spend around 1 trillion yen, or $6.32B, to jointly make next generation microchips used in image sensors, Nikkei Asia saysMicrosoftplans to significantly ramp production of its next-generation in-house AI chips next year, aiming to win adoption from major cloud customers such as Anthropic despite slow uptake of the current-generation chips, The Information reportsSanofiis facing shortages of Myozyme and Nexviazyme for Pompe disease after manufacturing and quality-control issues at its Waterford facility, which was cited by the FDA in June for violations involving production of other medicines, STAT says4. MOVERS:Bowman Consultinggained after announcingby Bernhard Capital for $43 per share and reporting Q2 resultsVarex Imagingincreased after announcing Teledynewillfor $18.90 per share in cash and reporting Q3 resultsMarineMaxwas higher after announcingby Safe Harbor for $53 per share in cashPowerFleetfell afterand cutting its guidance for FY27Lincoln Educationaland Bitdeerwere lower after5. EARNINGS/GUIDANCE:Surgery Partnersand backed its guidance for FY26N-ableand provided guidance for Q3 and FY26Aaonand raised its outlook for FY26, with CEO Matt Tobolski contending the results "demonstrate the continued strength of demand for our solutions and the progress we are making scaling the company to meet that demand"Monday.comand reaffirmed its outlook for FY26Accendra Healthand cut its outlook for FY26INDEXES:The Dow fell 60.95, or 0.11%, to 53,975.98, the Nasdaq lost 85.26, or 0.32%, to 26,605.36, and the S&P 500 declined 4.53, or 0.06%, to 7,753.11.

Major Averages Mixed at Open Amid Middle East Uncertainty

The major averages were mixed near noon to start the week, as traders are beginning to doubt that the U.S. and Iran will reach a lasting agreement to end the war in the near term. Balancing the negative sentiment around conflict in the Middle East are strong corporate earnings and optimism around AI spending.Iran is saying it is nearing an agreement with Oman on new shipping lanes but maintaining conditions that could delay a broader reopening. Meanwhile, Iranian Foreign Minister Abbas Araghchi said over the weekend that there was "no possibility of restarting negotiations" with the U.S. as long as Washington continues to violate the June memorandum of understanding. Oil prices were higher after the news.The market is also digesting last week's unexpectedly weak July jobs report, which showed payrolls fell by 23,000 and included substantial downward revisions to prior months. The report reduced expectations for a September Fed rate hike, but the outlook remains uncertain because inflation data due this week could complicate the picture. Investors will get the July CPI report Tuesday, followed by the PPI report later in the week.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Intelannounced aof common stockMetaunveiled open sourceGameStop'sRyan Cohen is considering withdrawing the company's $56B bid for eBay,Archer AviationBoeing'sWisk Aero, SkyGrid, and Insitu subsidiariesMonday.comreportedand reaffirmed its FY26 revenue guidance2. WALL STREET CALLS:JefferiesAppleto Underperform on apparent all-glass iPhone cancellationSanDiskto Buy at Argus on strong fundamentals and valuationDoximityto Underweight at Wells FargoHPEto Overweight at Morgan Stanley on server and storage spendingWall Streetof Csquarewith mostlybullish ratings3. AROUND THE WEB:Amazonis planning to invest in a large natural gas power plant to supply electricity directly to a major AI data center in Texas, underscoring how rapidly rising AI compute demand is driving tech companies to secure dedicated power generation, NYT reportsSonyand (TSMC) plan to spend around 1 trillion yen, or $6.32B, to jointly make next generation microchips used in image sensors, Nikkei Asia saysMicrosoftplans to significantly ramp production of its next-generation in-house AI chips next year, aiming to win adoption from major cloud customers such as Anthropic despite slow uptake of the current-generation chips, The Information reportsSanofiis facing shortages of Myozyme and Nexviazyme for Pompe disease after manufacturing and quality-control issues at its Waterford facility, which was cited by the FDA in June for violations involving production of other medicines, STAT saysImperial Brandsis preparing to cut thousands of jobs across the U.S. and Europe as part of a cost-cutting initiative, Bloomberg reports4. MOVERS:Bowman Consultinggains after announcing it will befor $43 per share and reporting Q2 resultsVarex Imagingincreases after announcing Teledynewillfor $18.90 per share in cash and reporting Q3 resultsMarineMaxhigher after announcing it will befor $53 per share in cashPowerFleetfalls afterand cutting its guidance for FY27Lincoln Educationaland Bitdeerlower after5. EARNINGS/GUIDANCE:Surgery Partnersand backed its guidance for FY26N-ableand provided guidance for Q3 and FY26Aaonand raised its outlook for FY26, with CEO Matt Tobolski contending the results "demonstrate the continued strength of demand for our solutions and the progress we are making scaling the company to meet that demand"Monday.comand reaffirmed its outlook for FY26Accendra Healthand cut its outlook for FY26INDEXES:Near midday, the Dow was down 20.58, or 0.04%, to 54,016.35, the Nasdaq was down 18.40, or 0.07%, to 26,672.22, and the S&P 500 was up 9.16, or 0.12%, to 7,766.80.

Several Companies Successfully Debut, BlossomHill Therapeutics Opens at $16.08

Several companies made their market debuts in the past week, highlighted by strong demand for new biopharma listings and a rare secondary only bank offering that drew attention for its structure.LATEST IPOS AND DIRECT LISTINGS:BlossomHill Therapeuticsopened on August 7 at $15.75. The company priced 9.375M shares at $16.00. The deal size was increased to 9.375M shares of common stock from 7.8M shares of common stock and priced within the $15.00-$17.00 range. BlossomHill Therapeutics is a clinical-stage biopharmaceutical company applying an intentional, chemistry-based approach to develop innovative small molecule medicines for the treatment of cancer.Latigo Biotherapeuticsopened on August 7 at $21. The clinical-stage biopharmaceutical company committed to developing innovative non-opioid pain medicines priced 19.2M shares at $18.00. The deal size was increased to 19.2M shares of common stock from 16M shares of common stock and priced at the high-end of the $16.00-$18.00 range.Ticketplusopened on August 7 at $7. The company priced 1.875M shares at $8.00. The deal priced at the low end of its $8.00-$10.00 range. Ticketplus is a technology company that operates a proprietary, full-stack technology platform powering live entertainment across Latin America.Braveheart Bioopened on August 6 at $30.20. The clinical-stage biopharmaceutical company developing next-generation therapeutics for hypertrophic cardiomyopathy and other serious cardiovascular diseases priced 21.25M shares at $18.00. The deal size was increased to 21.25M shares of common stock from 18.75M shares and priced above the $15.00-$17.00 range.River City Bankopened on August 6 at $45. The company priced its initial public offering of 2.7M shares of its common stock at a public offering price of $45.00 per share. The offering consists solely of existing shares held by two of the bank's longtime shareholders associated with the family of the bank's founder, Jon Kelly. As a result, the IPO is structured as a 100% secondary offering, with no new shares issued by the bank, River City noted. As of June 30, River City Bank had approximately $6.0B in assets, $4.7B in gross loans, and $5.4B in deposits.Attoviaopened on August 5 at $21.00. The company priced 17M shares at $17.00. The deal size was increased to 17M shares of common stock from 12.5M shares. The deal priced at the top of the $15.00-$17.00 range. All shares of common stock to be sold in the offering will be sold by Attovia. Attovia is a clinical-stage biopharmaceutical company developing next-generation biotherapeutics for immune-mediated diseases with high unmet need.RECENT SPAC IPOS:Pinnacle Acquisitionopened on August 7 at $9.97. Santander and CIBC Capital Markets are acting as joint book-running managers.TCGX Acquisitionopened on August 5 at $10.30. While the company may pursue an acquisition opportunity in any business, industry, sector or geographical location, it intends to focus its search on the healthcare and healthcare-related industries, particularly in the life sciences and medical technology sectors.PERFORMANCE:Prices as of 10:45 am ET on Monday, August 10 -BlossomHill Therapeutics – fractionally up at $16.08;Latigo Biotherapeutics – up over 1% at $18.47;Ticketplus – up more than 2% at $7.17;Braveheart Bio – fractionally up at $30.11;River City Bank – fractionally down at $46.76;Attovia – down almost 6% at $19.04;RECENT IPOS TO WATCH:Standard Nuclearand Csquareare already seeing coverage roll out, while QumulusAIis among stocks that could see new coverage this week as the quiet periods for banks that underwrote the companies' IPOs expire.UPCOMING IPOS:Upcoming IPO and direct listings expected include EvoAirand Inspire Brands.Clickto see upcoming IPO calendar on TipRanks.EvoAir Holdingshas filed for a firm commitment initial public offering of shares of common stock and anticipates that the initial public offering price of shares will be between $4.00 and $5.00 per share. The company said it will apply to list its common stock on the Nasdaq Capital Market under the symbol "EVOH". EvoAir Group is an emerging green technology focusing on eco-friendly heating, ventilation, air conditioning inventions and efforts in the environmental, social and governance initiatives. The Group is principally engaged in the research and development, manufacturing, sale and marketing of HVAC products for residential, commercial and industrial uses.Inspire Brandsannounced that it has confidentially submitted a draft registration statement on Form S-1 with the Securities and Exchange Commission relating to the proposed initial public offering of its common stock. Inspire Brands expects to use the net proceeds of the proposed offering to repay outstanding indebtedness under its existing term loan facility and pay offering fees and expenses."Opening Day" is The Fly's recurring series of stories on the latest initial public offerings, their performance, and upcoming IPOs.